EDS
Equine Diagnostic Solutions (EDS) is a Lexington, Kentucky-based specialty laboratory providing serologic and molecular diagnostic testing exclusively for equine veterinarians worldwide, with a focus on infectious disease panels covering respiratory, neurologic, and gastrointestinal conditions.
- Company typePrivate
- Founded2009
- HeadquartersLexington, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What EDS does
Equine Diagnostic Solutions (EDS) is a privately held specialty diagnostic laboratory founded in August 2009 in Lexington, Kentucky, by co-founders Jennifer K. Morrow, PhD and Amy J. Graves, MT(ASCP). The company is dedicated exclusively to equine infectious disease testing, serving equine veterinarians worldwide through direct sample submission. The laboratory operates with a small team of approximately five staff including the founders, a senior technologist, and additional technologists.
EDS's core offering is a portfolio of serologic and molecular diagnostic assays organized into disease-specific panels covering respiratory (Streptococcus equi, EHV-1/4, equine influenza, etc.), neurologic (EPM, West Nile Virus, EHV-1 with ORF-30 mutation), and gastrointestinal (Salmonella, C. difficile, equine coronavirus, etc.) diseases. The company holds an exclusive license for the second generation SAG 2/4/3 ELISA for Sarcocystis neurona with serum:CSF ratio methodology, its flagship EPM diagnostic, alongside a SeM ELISA for strangles and multiplex real-time PCR capabilities. EDS also continues to perform first-generation western blot analysis for S. neurona.
EDS generates revenue on a pay-as-you-go basis per diagnostic test, with pricing not publicly disclosed and a downloadable service list PDF available to clients. Sample logistics are facilitated through a discounted UPS Next Day Air partnership with seasonal Saturday delivery. The company's go-to-market is sales-led and community-driven, anchored by annual participation in the American Association of Equine Practitioners (AAEP) conference, direct phone/email customer support, and collaborations with equine researchers. A Customer Portal is in development to modernize the client submission and tracking experience.
EDS firmographics
Firmographics- Name
- EDS
- Legal name
- Equine Diagnostic Solutions LLC
- Website
- https://edslabky.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Equine Diagnostic Solutions (EDS) is a Lexington, Kentucky-based specialty laboratory providing serologic and molecular diagnostic testing exclusively for equine veterinarians worldwide, with a focus on infectious disease panels covering respiratory, neurologic, and gastrointestinal conditions.
- Ownership category
- akta.pro rank
EDS industry classification
Industry- Product category
- Veterinary Diagnostic Laboratory Services
- NAICS
- Veterinary Services (54194)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA)
Keywords
Where EDS is headquartered
LocationHeadquarters
- HQ city
- Lexington
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
EDS business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic Testing Services: Laboratory testing services for equine infectious diseases including respiratory, neurologic, and GI disease panels. Revenue generated per test based on service list pricing. Customers include equine veterinarians worldwide submitting samples for diagnostic testing.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Next Day Air shipping fee |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
EDS product offering
Product offeringCore offering
EDS is an equine-dedicated diagnostic testing laboratory that performs serologic (ELISA, Western Blot) and molecular (multiplex real-time PCR) assays on samples submitted by equine veterinarians worldwide. The company organizes its testing into neurologic, respiratory, and GI disease panels covering pathogens such as Sarcocystis neurona (EPM), Streptococcus equi (strangles), EHV-1/4, equine influenza, West Nile Virus, Salmonella, C. difficile toxins, and equine coronavirus. It holds an exclusive license for the second-generation SAG 2/4/3 ELISA used in EPM diagnostics.
Product overview
Equine Diagnostic Solutions (EDS) operates as a specialized equine diagnostic testing laboratory offering a comprehensive portfolio of diagnostic services for equine veterinarians worldwide. The core offering consists of disease-specific diagnostic testing panels organized by body system: neurologic disease panels, respiratory disease panels, and GI disease panels. EDS provides both serologic assays (including the exclusive SAG 2/4/3 ELISA and traditional western blot) and molecular assays (multiplex real-time PCR). Notable proprietary offerings include the exclusive license for the 2nd generation SAG 2/4/3 ELISA for Sarcocystis neurona and the SeM ELISA for Streptococcus equi testing. The laboratory is developing a Customer Portal for client access (currently marked 'COMING SOON').
Differentiator
Problem solved
Functional benefit
Products and services
- Equine Diagnostic Testing Services
- Neurologic Disease Panels
- Respiratory Disease Panels
- GI Disease Panels
- SAG 2/4/3 ELISA for Sarcocystis neurona
- SeM ELISA for Streptococcus equi
- Multiplex Real-time PCR Sample Processing
- Western Blot Analysis for Sarcocystis neurona
Quantifiable outcome
- Improved EPM diagnostics through serum:CSF ratio methodology
Companies that use EDS
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
EDS technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
EDS partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights4 records
EDS competitors and assessment
Company assessmentBroad incumbents
- Antech Diagnostics (Mars Petcare): Large veterinary reference laboratory network in North America offering a broad infectious disease menu. Overlaps with EDS on equine infectious disease testing though Antech is a broad multi-species lab.
- Heska (Mars Petcare): Veterinary diagnostics company (now part of Mars) with in-clinic analyzers and reference lab services. Competes with EDS in point-of-care and specialty testing for animal health.
- Zoetis Diagnostics: Animal health giant offering diagnostic products and reference lab services (Vetscan, reference lab network). Targets livestock and equine segments, directly competing with EDS for equine diagnostic tests.
- IDEXX Laboratories: Global leader in veterinary diagnostics (companion animal and livestock) with reference lab services, in-clinic instruments, and equine test offerings. Competes with EDS for equine sample submissions but as part of a much broader portfolio.
Direct peers
- Neogen: Animal safety and genomics company with molecular and serologic diagnostics for livestock and equine pathogens, including Salmonella and EPM-related assays. Closest comparable to EDS in technology and species focus.
- Cornell University Animal Health Diagnostic Center: Major academic veterinary diagnostic laboratory offering serologic and molecular testing for equine infectious diseases including EPM, EHV, and respiratory pathogens. Competes for out-of-state equine submissions.
- TVMDL (Texas A&M Veterinary Medical Diagnostic Laboratory): State-funded veterinary diagnostic laboratory conducting serologic and molecular testing for equine infectious diseases including EPM, EHV-1, and influenza. Directly competes for equine sample submissions.
- University of Kentucky Veterinary Diagnostic Laboratory: Academic veterinary diagnostic lab in Lexington, KY (same city as EDS) offering equine infectious disease testing including EPM serology. Strong local overlap with EDS's Central Kentucky customer base.
Emerging players
- VDx Veterinary Diagnostics: Specialized veterinary diagnostics laboratory offering molecular and serologic testing for infectious diseases. Closely comparable niche reference lab model to EDS, with overlap in equine and small animal testing.
Others
- Bio-Rad Laboratories: Life sciences diagnostics manufacturer and reference lab provider (owner of some equine ELISA kits). Comparable as a supplier/adjacent provider whose assays and internal labs compete with EDS's service offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks7 records
Key highlights7 records
Customer concentration
EDS compliance and trust
Trust signalCompliance1 record
EDS financial estimates
Financial estimateRevenue estimate
Valuation estimate
EDS leadership team
Management profileNumber of profiles
Profiles6 records
EDS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EDS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EDS
What does EDS do?
EDS is an equine-dedicated diagnostic testing laboratory that performs serologic (ELISA, Western Blot) and molecular (multiplex real-time PCR) assays on samples submitted by equine veterinarians worldwide. The company organizes its testing into neurologic, respiratory, and GI disease panels covering pathogens such as Sarcocystis neurona (EPM), Streptococcus equi (strangles), EHV-1/4, equine influenza, West Nile Virus, Salmonella, C. difficile toxins, and equine coronavirus. It holds an exclusive license for the second-generation SAG 2/4/3 ELISA used in EPM diagnostics.
Is EDS a public or private company?
EDS is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was EDS founded?
EDS was founded in 2009. It employs 1 to 10 people.
Where is EDS based?
EDS is headquartered in Lexington, United States, in the North America region.
How does EDS make money?
One revenue line is on record: diagnostic Testing Services.
Who are EDS's main competitors?
Broad incumbents on record are Antech Diagnostics (Mars Petcare), Heska (Mars Petcare), Zoetis Diagnostics and IDEXX Laboratories. Direct peers are Neogen, Cornell University Animal Health Diagnostic Center, TVMDL (Texas A&M Veterinary Medical Diagnostic Laboratory) and University of Kentucky Veterinary Diagnostic Laboratory. VDx Veterinary Diagnostics is listed as an emerging player. Bio-Rad Laboratories is listed as an others.
Does EDS have an API?
No public API is recorded for EDS.
What industry is EDS in?
EDS's product category is Veterinary Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAMADAA, Reference Laboratory Testing (Clinical Pathology & Chemistry). Its NAICS code is 54194 and its SIC code is 8071.